Hrt Financial LP Design Therapeutics, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.99 - $2.76 $81,028 - $112,381	40,718 New	40,718 $107,000
Q2 2023 Aug 11, 2023	SELL	$4.99 - $7.64 $148,198 - $226,900	-29,699 Reduced 23.77%	95,264 $600,000
Q1 2023 May 12, 2023	BUY	$5.5 - $9.77 $687,296 - $1.22 Million	124,963 New	124,963 $721,000
Q2 2022 Aug 12, 2022	BUY	$9.91 - $17.33 $401,582 - $702,263	40,523 New	40,523 $567,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.